UNSPSC 51101914: Artesunate

This classification denotes an antiprotozoal agent with the molecular formula C19H28O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 60W3249T9M, chemically known as 4-oxo-4-(((3r,5as,6r,8as,9r,10s,12r,12ar)-3,6,9-trimethyldecahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10-yl hydrogen butanedioate but generally known as artesunate, which bears US NIH Compound Identifier 65664. European Medicines Agency schedules Artesunate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05576MIG.

UNSPSC 51101914 Artesunate, a Commodity code, does not map clearly to the state and local opportunities posted under it. The recent solicitations tagged to this code instead cover naloxone and drug deactivation systems, medical and first aid supplies for emergency response, and generic pharmaceuticals and OTC products through cooperative purchasing — none of which involve artesunate specifically, an antimalarial pharmaceutical with limited domestic demand outside specialized tropical-medicine contexts. The code shows little relevant recent activity aligned with its nominal scope.

The four opportunities posted under this code originate from a mixed issuing-body set including a county health department (Seminole County, Florida), a state health and human services commission (Texas HHS), a municipal fire department (City of Tampa), and a multi-state cooperative purchasing alliance (MMCAP, administered by Minnesota). The geographic spread spans Florida, Texas, Minnesota, and participating states in the MMCAP cooperative, including Oregon. Representative solicitations include Seminole County's IFB60459723LAS (due July 26, 2023) for naloxone and drug deactivation systems under an IFB notice; the City of Tampa's 26P00145 (due March 13, 2026) for medical and first aid supplies to the Fire Department Rescue Division under an ITB notice, estimated at $700,000, with a 5 percent bid discount reserved for certified Small Local Business Enterprises; and MMCAP's S1070000015802 RFP (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, with award effective July 1, 2026. The mismatch between the code's scope and the actual solicitations suggests either a tagging error or that artesunate has minimal state and local procurement volume.